Pharma Companies Try 'DRM' For Drugs As A Ploy To Stymie Generics

One of the striking features of the drug world is how pharma companies become noticeably more inventive immediately before their patents are due to run out and their drugs are about to enter the public domain. That's because they need to find a way to differentiate themselves from the generic manufacturers that are then able to offer the same medicines for often vastly lower prices. 

On Techdirt.